Cargando…
Variant constraint by mRNA vaccines
The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034506/ https://www.ncbi.nlm.nih.gov/pubmed/33837367 http://dx.doi.org/10.1038/s41577-021-00548-5 |
_version_ | 1783676555066605568 |
---|---|
author | Bordon, Yvonne |
author_facet | Bordon, Yvonne |
author_sort | Bordon, Yvonne |
collection | PubMed |
description | The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants. |
format | Online Article Text |
id | pubmed-8034506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80345062021-04-12 Variant constraint by mRNA vaccines Bordon, Yvonne Nat Rev Immunol Research Highlight The currently licensed mRNA vaccines for SARS-CoV-2 can elicit cross-neutralizing antibodies against B.1.351 variants of the virus, but are less potent against these variants. Nature Publishing Group UK 2021-04-09 2021 /pmc/articles/PMC8034506/ /pubmed/33837367 http://dx.doi.org/10.1038/s41577-021-00548-5 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Highlight Bordon, Yvonne Variant constraint by mRNA vaccines |
title | Variant constraint by mRNA vaccines |
title_full | Variant constraint by mRNA vaccines |
title_fullStr | Variant constraint by mRNA vaccines |
title_full_unstemmed | Variant constraint by mRNA vaccines |
title_short | Variant constraint by mRNA vaccines |
title_sort | variant constraint by mrna vaccines |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034506/ https://www.ncbi.nlm.nih.gov/pubmed/33837367 http://dx.doi.org/10.1038/s41577-021-00548-5 |
work_keys_str_mv | AT bordonyvonne variantconstraintbymrnavaccines |